ARTICLE | Finance
Next phase for Phase4
Phase4 Ventures spins out from Nomura, plans new Euro focused biotech fund
February 14, 2011 8:00 AM UTC
Phase4 Ventures expects to focus more on European investment following its spinout from Nomura. The firm will be raising its first independent fund sometime over the next 12 months.
The new firm expects to invest upwards of 50% in Europe, while under Nomura that proportion was about 35%, Managing Partner Denise Pollard-Knight told Ebb & Flow...